Open AccessAdding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial
Author(s) -
Alaa Rahhal,
Mostafa Najim,
Amer Hussein Aljundi,
Ahmed Mahfouz,
Sumaya Mehdar Alyafei,
Ahmed Awaisu,
Mhd Baraa Habib,
Ibrahim Mohammad Obeidat,
Mohanad Faisal,
Meshaal Alanzi,
Arun Prabhakaran Nair,
Areeg Elhassan,
Abdullah Aldushain,
Alaaeldin Abdelmajid,
Ahmed Elfadil Abdelgader,
Ahmed Moursi,
Ahmad Alharafsheh,
Mohd Ragheb Abou Kamar,
Wael Goravey,
Amr S Omar,
Mohammed Abukhattab,
Mohamad Khatib,
Mohamed Gaafar Mohamedali,
Muna Almaslamani,
Samar AlEmadi
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000030843
Subject(s) - medicine , tocilizumab , colchicine , randomized controlled trial , pneumonia , cytokine storm , covid-19 , rheumatoid arthritis , disease , infectious disease (medical specialty)